ArticleJAMA network open2022
Use of Menthol Cigarettes, Smoking Frequency, and Nicotine Dependence Among US Youth.
Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 21 citations in OpenAlex.
- Switching from menthol to non-menthol cigarettes does not impact acute responses to intravenous nicotine.Pharmacology, biochemistry, and behavior · 2025Trial
- Does removing menthol cigarettes in convenience stores reduce susceptibility to cigarette smoking? An experimental investigation in young people.Drug and alcohol dependence · 2023Trial
- Public Comments and Federal Rulemaking for Menthol Cigarettes and Flavored Cigars.JAMA network open · 2026Article
- Demographic predictors of menthol cigarette and flavored e-cigarette restriction policy support among a cross-sectional sample of U.S. adults.BMC public health · 2026Article
- Systematic Assessment of Flavor Cues and Additives in Cigarettes and Heated Tobacco Products in Korea: Cross-Sectional Surveillance Study.JMIR public health and surveillance · 2026Article
- β-Nicotyrine and e-cigarette abuse liability II: Behavioral economic demand and intracranial self-stimulation in rats.Drug and alcohol dependence · 2026Article
- Youth and young adult flavour expectancies for new 'non-menthol' cigarettes introduced following California's ban on flavoured tobacco products.Tobacco control · 2025Article
- How does removing menthol tobacco product displays at point-of-sale affect adolescents' cigarette smoking intentions? The mediating effects of social norms.Journal of behavioral medicine · 2025Article
- "Ice" flavor elements in E-cigarette images: Influence on liking and intention to use among youth who are at risk of E-cigarette use.Drug and alcohol dependence · 2025Article
- Global landscape of nicotine and tobacco products additives policies.Tobacco control · 2024Article
- Applications of an Electrochemical Sensory Array Coupled with Chemometric Modeling for Electronic Cigarettes.Sensors (Basel, Switzerland) · 2024Article
- More than a "characterizing flavor": Menthol at subliminal levels in tobacco products.Drug and alcohol dependence · 2024Review
- Use of Menthol-Flavored Tobacco Products Among US Middle and High School Students: National Youth Tobacco Survey, 2022.Preventing chronic disease · 2024Article
- [Current Status of Flavored Tobacco Products Use].Jugan geon-gang gwa jilbyeong · 2023Article
- Disparities in thoracic surgical oncology.Journal of surgical oncology · 2023Review
- US Food and Drug Administration Action on Menthol Cigarettes and Flavored Cigars-A Pivotal Moment for Health Equity.JAMA network open · 2022Article
- Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Importance: Menthol may make cigarette smoke less aversive and could lead youth to smoke more frequently and become more dependent on nicotine. Objective: To assess the association of menthol use with cigarette smoking frequency and nicotine dependence (ND) among youth cigarettes users. Design, Setting, and Participants: This cohort study used a pooled sample of cohorts of US youth (aged 12-17 years at their baseline and follow-up interviews) in the Population Assessment of Tobacco and Health Study (September 2013 to November 2019). Household interviews were conducted using audio computer-assisted self-interviews. US youth who were past-30-day cigarette smokers at any of wave 2 through wave 5, completed the preceding survey (eg, wave 2 past-30-day cigarette smokers completed wave 1), and indicated whether they used menthol cigarettes were eligible. The association of menthol use with smoking frequency and ND was estimated using inverse probability of treatment weighting adjusted mean differences (aMDs), adjusted risk ratios (aRRs), and corresponding 95% CIs. Data were analyzed from December 2021 to March 2022. Exposures: Menthol use and transitions in use (switching to or from menthol cigarettes). Main Outcomes and Measures: Main outcomes were the number of days smoked in the past 30 days, the risk of frequent smoking (smoking ≥20 days in the past 30 days), and symptoms of ND. Results: There were a total of 1492 observations among 1096 US youth cigarette smokers, of whom 49.4% were female, 67.2% were non-Hispanic White, and 28.7% were aged 12 to 14 years at their baseline survey (all percentages are weighted). Among those who switched from not smoking to smoking (61% of the sample), menthol use was associated with smoking on 3.1 additional days (aMD; 95% CI, 1.9 to 4.2 days), 59% higher risk of being a frequent smoker (aRR, 1.59; 95% CI, 1.23 to 2.06), and 10% higher ND scores (aMD, 1.09; 95% CI, 1.02 to 1.17). Switching from smoking menthol to smoking nonmenthol (vs maintaining menthol use) was associated with smoking on 3.6 fewer days (aMD; 95% CI, -6.3 to -0.9 days) and 47% lower risk of being a frequent smoker (aRR, 0.68; 95% CI, 0.50 to 0.92). Conclusions and Relevance: These findings suggest that the addition of menthol to cigarettes is associated with increased smoking frequency and ND among US youth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.